| Date: | 10/21/2016 |
|---|---|
| Organization: | Department of Public Health |
| Regulatory Authority: | MGL c. 111, §§ 3, 4E, 5, 6, 24A, 110A |
| Official Version: | Purchase the official print version |
105 CMR 270.000: (A) lists those diseases and disorders with treatments that are known to be more effective if the condition is identified in the newborn/infant period and for which there is a reliable and effective blood screening test and diagnostic protocol; (B) ensures that every newborn is screened for markers of these diseases and disorders; and (C) makes available Optional Newborn Blood Screening for another set of diseases and disorders with treatments that are thought to be effective if the condition is identified in the newborn/infant period and for which testing shall be offered under an optional protocol to collect critical population-based data on prevalence of these diseases and disorders in the Massachusetts population, their natural history, and the efficacy of screening, diagnostic, and treatment protocols.
Download a PDF copy of the regulation below.